Novel potent and selective αvβ3/αvβ5 integrin dual antagonists with reduced binding affinity for human serum albumin
- 1 July 2006
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 41 (7) , 847-861
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acidsBioorganic & Medicinal Chemistry Letters, 2005
- Solid-phase synthesis of a small library of 3-phenylthio-3-nicotinyl propionic acid derivatives acting as antagonists of the integrin αVβ3Bioorganic & Medicinal Chemistry Letters, 2004
- Nonpeptide αvβ3 Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent αvβ3 Antagonist for the Prevention and Treatment of OsteoporosisJournal of Medicinal Chemistry, 2003
- Non-Peptide αvβ3 antagonists. Part 6: Design and synthesis of αvβ3 antagonists containing a pyridone or pyrazinone central scaffoldBioorganic & Medicinal Chemistry Letters, 2003
- Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonistsBioorganic & Medicinal Chemistry Letters, 2003
- IntegrinsCell, 2002
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Protein binding of quinolonecarboxylic acids. I. Cinoxacin, nalidixic acid and pipemidic acid.Chemical and Pharmaceutical Bulletin, 1989
- Complete amino acid sequence of human serum albuminFEBS Letters, 1975
- Amino acid sequence adjoining the lone tryptophan of human serum albumin. A binding site of the proteinBiochemistry, 1970